|
KPTI
Karyopharm Therapeutics Inc.
KPTI · Q4 FY2025
|
Q4 FY2025 |
|
KPTI Q4 FY2025 transcript
|
|
LITB
LightInTheBox Holding Co., Ltd.
LITB · Q4 FY2025
|
Q4 FY2025 |
|
LITB Q4 FY2025 transcript
|
|
HSAI
Hesai Group
HSAI · Q4 FY2025
|
Q4 FY2025 |
|
HSAI Q4 FY2025 transcript
|
|
CDLR
Cadeler A/S
CDLR · Q4 FY2025
|
Q4 FY2025 |
|
CDLR Q4 FY2025 transcript
|
|
PAYS
Paysign, Inc.
PAYS · Q4 FY2025
|
Q4 FY2025 |
|
PAYS Q4 FY2025 transcript
|
|
LENZ
LENZ Therapeutics, Inc.
LENZ · Q4 FY2025
|
Q4 FY2025 |
|
LENZ Q4 FY2025 transcript
|
|
ACHV
Achieve Life Sciences, Inc.
ACHV · Q4 FY2025
|
Q4 FY2025 |
|
ACHV Q4 FY2025 transcript
|
|
VELO
Velo3D, Inc.
VELO · Q4 FY2025
|
Q4 FY2025 |
|
VELO Q4 FY2025 transcript
|
|
CNM
Core & Main, Inc.
CNM · Q4 FY2026
|
Q4 FY2026 |
|
CNM Q4 FY2026 transcript
|
|
BRZE
Braze, Inc.
BRZE · Q4 FY2026
|
Q4 FY2026 |
|
BRZE Q4 FY2026 transcript
|
|
CNXC
Concentrix Corp
CNXC · Q1 FY2026
|
Q1 FY2026 |
|
CNXC Q1 FY2026 transcript
|
|
AIR
Aar Corp
AIR · Q3 FY2026
|
Q3 FY2026 |
|
AIR Q3 FY2026 transcript
|
|
GUTS
Fractyl Health, Inc.
GUTS · Q4 FY2025
|
Q4 FY2025 |
|
GUTS Q4 FY2025 transcript
|
|
KBH
Kb Home
KBH · Q1 FY2026
|
Q1 FY2026 |
|
KBH Q1 FY2026 transcript
|
|
DLMAY
Dollarama Inc./ADR
DLMAY · Q4 FY2025
|
Q4 FY2025 |
|
DLMAY Q4 FY2025 transcript
|
|
BCDA
BioCardia, Inc.
BCDA · Q4 FY2025
|
Q4 FY2025 |
|
BCDA Q4 FY2025 transcript
|
|
CMCM
Cheetah Mobile Inc.
CMCM · Q4 FY2025
|
Q4 FY2025 |
|
CMCM Q4 FY2025 transcript
|
|
TELA
TELA Bio, Inc.
TELA · Q4 FY2025
|
Q4 FY2025 |
|
TELA Q4 FY2025 transcript
|
|
INTZ
Intrusion Inc
INTZ · Q4 FY2025
|
Q4 FY2025 |
|
INTZ Q4 FY2025 transcript
|
|
BSEM
BioStem Technologies, Inc.
BSEM · Q4 FY2025
|
Q4 FY2025 |
|
BSEM Q4 FY2025 transcript
|
|
PESI
Perma Fix Environmental Services Inc
PESI · Q4 FY2025
|
Q4 FY2025 |
|
PESI Q4 FY2025 transcript
|
|
MOB
Mobilicom Ltd
MOB · Q4 FY2025
|
Q4 FY2025 |
|
MOB Q4 FY2025 transcript
|
|
NOAH
Noah Holdings Ltd
NOAH · Q4 FY2025
|
Q4 FY2025 |
|
NOAH Q4 FY2025 transcript
|
|
BZAI
Blaize Holdings, Inc.
BZAI · Q4 FY2025
|
Q4 FY2025 |
|
BZAI Q4 FY2025 transcript
|